Aclarion, Inc. ( (ACON) ) just unveiled an update. Aclarion, Inc. announced the pricing of a registered direct offering of common stock, selling 3,380,276 shares at $0.142 per share to raise approximately $480,000. The proceeds will be used for market development, clinical evidence, product development, quality improvement, and general corporate purposes, with Dawson James Securities acting as the sole placement agent. More about Aclarion, Inc. Aclarion, Inc. is a healthcare technology company t